CI Platform
Sign in
Original Biomedicals Co Ltd6483Unknown exchange
Current ReportFundamental Reports

Asia / TAIWAN

Report Sections1

Available for this company

Reporting UnitBillions

Unknown exchange

Company Overview

Original BioMedicals Co., Ltd. engages in the development of non-new ingredients new drugs. Its products include radiation injury prevention drug with amifostine compound, amifostine combined microcellular chemotherapy adjuvant, and peptide-like compound for the treatment of microcellular diabetes. The company was founded by Chia Hung Chen on December 05, 2011 and is headquartered in Tainan, Taiwan.

Original BioMedicals Co., Ltd. engages in the development of non-new ingredients new drugs. Its products include radiation injury prevention drug with amifostine compound, amifostine combined microcellular chemotherapy adjuvant, and peptide-like compound for the treatment of microcellular diabetes. The company was founded by Chia Hung Chen on December 05, 2011 and is headquartered in Tainan, Taiwan.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryPharmaceutical Preparations
CountryTAIWAN
Employees15
Reporting UnitBillions
Primary ExchangeUnknown exchange
Instrument TypeEquity
Wright IDC158WXMT3

Key Metrics

Current price$15.80
Market cap$1.06 B
P/E ration/a
52-week perf.+45.6%
Common shares66.8 M
Share typeGu
Quality ratingLBD0
Dividend yield0.00%

Recent stock performance

1 Week+8.2%
4 Week+20.1%
13 Week+9.7%

Officers

n/a

Address

TAIWAN

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.